|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1001 Pennsylvania Avenue NW |
Address2 | Suite 710 |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 6484-12
|
||||||||
|
6. House ID# 314020000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Elizabeth Hall |
Date | 4/20/2018 4:07:11 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment, transitional policies)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance)
The Bipartisan Budget Act of 2018 (H.R. 1892)
Bipartisan Health Care Stabilization Act of 2018 (Amendment to S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018)
Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act of 2017 (S. 974 and H.R. 2212)
Overdose Prevention and Patient Safety Act (H.R. 3545)
Jessies Law (H.R. 5009)
Prescription Drug Monitoring Act of 2017 (S. 778)
CARA 2.0 Act of 2018 (S. 2456)
Consolidated Appropriations Act, 2018 (H.R. 1625)
Lower Premiums Through Reinsurance Act (S. 1835)
Mental health and substance use (42 CFR Part 2)
Individual market and exchange stabilization
Association health plans
Short Term Limited Duration Plans
Out of network billing
ACA third party payments
Telehealth
Price of prescription drugs
Opioid addiction issues and response (prescription drug monitoring programs)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office, Labor - Dept of (DOL)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Hall |
|
|
|
Samuel |
Marchio |
|
|
|
Adam |
Goldberg |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment, transitional policies)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance)
The Bipartisan Budget Act of 2018 (H.R. 1892)
Bipartisan Health Care Stabilization Act of 2018 (Amendment to S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018)
Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act of 2017 (S. 974 and H.R. 2212)
Overdose Prevention and Patient Safety Act (H.R. 3545)
Jessies Law (H.R. 5009)
Prescription Drug Monitoring Act of 2017 (S. 778)
CARA 2.0 Act of 2018 (S. 2456)
Consolidated Appropriations Act, 2018 (H.R. 1625)
Lower Premiums Through Reinsurance Act (S. 1835)
Mental health and substance use (42 CFR Part 2)
Individual market and exchange stabilization
Association health plans
Short Term Limited Duration Plans
Out of network billing
ACA third party payments
Telehealth
Price of prescription drugs
Opioid addiction issues and response (prescription drug monitoring programs)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office, Labor - Dept of (DOL)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Hall |
|
|
|
Samuel |
Marchio |
|
|
|
Adam |
Goldberg |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members, reauthorization of special need plans (including H.R. 3168), star ratings, normalization factors, stars contract consolidation)
Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 (S. 870 and H.R. 4579)
Mental health and substance use (42 CFR Part 2)
The Bipartisan Budget Act of 2018 (H.R. 1892)
The Connect for Health Act of 2017 (H.R.2556 and S.1016)
Medicaid managed care
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Medicare Part D
Clinical decision support
Medicare fraud, waste, and abuse
Opioid addiction issues and response (prescription drug monitoring programs)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Hall |
|
|
|
Samuel |
Marchio |
|
|
|
Adam |
Goldberg |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
To extend the one year moratorium and/or repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act (H.R. 246)
Healthcare Tax Relief Act (S. 1859)
Small Business and Family Health Tax Relief Act of 2017 (S. 1978)
The Bipartisan Budget Act of 2018 (H.R. 1892)
Tax exclusion for employer-sponsored health insurance
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Hall |
|
|
|
Samuel |
Marchio |
|
|
|
Adam |
Goldberg |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Telephone Consumer Protection Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samuel |
Marchio |
|
|
|
Adam |
Goldberg |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |